Earlier this year, researchers reported phase III Austrian Breast &Colorectal Cancer Study that zoledronic acid added to endocrine therapy improves survival in premenopausal breast cancer patients.

• 今年早些时候，研究者们报道奥地利的乳腺癌和结肠癌三期患者研究表明，内分泌治疗辅助唑来膦酸治疗可以提高绝经前乳腺癌患者的存活率。